Kerusso Capital Management LLC

Position in GILD — Gilead Sciences, Inc.

CIK 2029597 Winston Salem, NC

Position in GILD

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$6,365,640

+$676,278 QoQ

Shares Held

50,385

+23.4% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

2.32%

of 13F equity value

Holder Rank

#523

of 2,266 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 71% Shared 0% None 29%

Healthcare · as of Jun 30, 2026

Kerusso Capital Management LLC holds $25,879,752 across 6 Drug Manufacturers - General names. GILD ranks #1 (24.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GILD	Gilead Sciences, Inc. This page	50,385	$6,365,640
2	ABBV	AbbVie Inc.	22,511	$5,664,668
3	AMGN	Amgen Inc	15,282	$5,533,917
4	BMY	Bristol Myers Squibb Co	77,798	$4,482,720
5	MRK	Merck & Co., Inc.	16,017	$2,058,184
6	PFE	Pfizer Inc	73,697	$1,774,623

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,365,640	50,385	+23.4%	Shares	Sole	2026-07-31
2026-03-31	$5,689,362	40,822	-6.6%	Shares	Sole	2026-05-14
2025-12-31	$5,366,192	43,720	+31.3%	Shares	Sole	2026-01-28
2025-09-30	$3,696,189	33,299	-5.7%	Shares	Sole	2025-10-28
2025-06-30	$3,916,039	35,321	+0.0%	Shares	Sole	2025-08-04
2025-03-31	$3,955,813	35,304	+2.6%	Shares	Sole	2025-05-12
2024-12-31	$3,178,359	34,409	+0.2%	Shares	Sole	2025-01-31
2024-09-30	$2,878,478	34,333	+6.4%	Shares	Sole	2024-11-01
2024-06-30	$2,213,701	32,265	—	Shares	Sole	2024-08-06
No filing history on record for this holder in this stock.